ESMO Calls for Cancer Care Integration in EU Global Health Resilience Initiative (GHRI) By Ogkologos - March 24, 2026 8 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia FDA Approves Teclistamab in Combination with Daratumumab Hyaluronidase-fihj for Relapsed or Refractory Multiple Myeloma FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer MOST POPULAR How I’m Working to Erase the Stigma of Lung Cancer: A... November 22, 2023 EMA Recommends Granting a Marketing Authorisation for Akeega, Fixed-Dose Combinations of... March 10, 2023 FDA Approves a Fixed-Dose Combination of Nivolumab and Relatlimab for Unresectable... April 12, 2022 Breaking the silence: when cancer steals your voice December 2, 2022 Load more HOT NEWS Our sun safety messaging tours the UK with the NIVEA Sun... Health inequalities: Why is it harder for some people to eat... FDA Approves Nirogacestat for Desmoid Tumours New on NCI Websites for December 2018
